Corcept Therapeutics president reports sale of common shares worth $674,068.7958
CORT•Corcept Therapeutics President, Oncology Roberto Wandenkolk Vieira sold 8,333 common shares on Nov. 2, 2026, for a reported $674,068.7958. He also exercised options for 8,333 shares at $21.63 each.
1. Share sale and options
Vieira sold 6,657 shares at $80.7326 each and 1,676 shares at $81.5226 each. A Nov. 4 filing reported that he held 3,946 common shares directly and had 125,001 stock options remaining.
